Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637)
10/2011
10/27/2011US20110263460 Compositions and methods for producing replication competent human immunodeficiency virus (hiv)
10/27/2011US20110263027 Adeno-associated virus (AAV) sequences and isolating novel sequences identified thereby
10/27/2011US20110263001 Compositions and Methods for Engineering Cells
10/27/2011US20110262991 Living Copolymer-Protein/Peptide Hybrids for Biomedical Applications
10/27/2011US20110262965 Cell culture medium comprising small peptides
10/27/2011US20110262897 Imaging techniques using a tridentate ligand
10/27/2011US20110262481 High growth reassortant influenza a virus
10/27/2011US20110262474 Chimeric HIV Antigens
10/27/2011US20110262447 Human synthetic single-chain antibodies directed against the common epitope of mutant p53 and their uses
10/27/2011US20110262399 Porphobilinogen deaminase gene therapy
10/27/2011DE102010018961A1 Genetisch modifiziertes Paramyxovirus zur Behandlung von Tumorerkrankungen Genetically modified Paramyxovirus in the treatment of tumor diseases
10/27/2011CA2833908A1 Cns targeting aav vectors and methods of use thereof
10/26/2011EP1660678B1 Mutant adeno-associated virus virions and methods of use thereof
10/26/2011EP1463822B1 Method for the production of cell lines with latent immunodeficiency virus
10/26/2011EP1409748B1 Recombinant Adenoviruses comprising simian adenovirus proteins and uses thereof.
10/26/2011EP0787191B2 Nucleotide sequences of hiv-1 type (or subtype) o retrovirus antigens
10/25/2011US8044175 Peptides that specifically bind HGF receptor (CMET) and uses thereof
10/25/2011US8043856 Adenoviral vectors for influenza virus production
10/25/2011US8043831 Therapeutic agents comprising pro-apoptotic proteins
10/25/2011US8043624 Compositions and methods for treatment of microbial infections
10/25/2011US8043612 Infection and treatment of neoplasms with vesicular stomatitis virus
10/25/2011US8043611 Regulated nucleic acid expression system
10/25/2011US8043610 Freeze-dried composition of inactivated virus envelope with membrane fusion activity
10/25/2011CA2544462C Immortalized avian cell lines for virus production
10/25/2011CA2448329C Development of mutations useful for attenuating dengue viruses and chimeric dengue viruses
10/25/2011CA2374505C Methods for display of heterodimeric proteins on filamentous phage using pvii and pix, compositions, vectors and combinatorial libraries
10/25/2011CA2372709C Vector for integration of heterologous sequences into poxviral genomes
10/20/2011WO2011130119A2 Methods of producing high titer, high purity virus stocks and methods of use thereof
10/20/2011US20110257080 Hepatitis B Virus Compositions and Methods of Use
10/20/2011US20110257028 Method for selectively binding a substrate to sorbents by way of at least bivalent bonds
10/20/2011US20110256576 Recovery and detection of microorganisms from mixed cellulose ester filtration supports by sequential treatment with methanol and acetone
10/20/2011US20110256525 Compositions and methods for purifying and crystallizing molecules of interest
10/20/2011US20110256524 Recombinant adenovirus comprising tissue-specific promoter and tumor-targeting trans-splicing ribozyme and uses thereof
10/20/2011US20110256174 Rabies vaccine
10/20/2011US20110256104 Complexing agents for compositions containing inclusion complexes
10/19/2011EP2377927A1 Methods of producing high titer, high purity virus stocks and methods of use thereof
10/19/2011EP2376640A1 Methods and compositions for use of a coccidiosis vaccine
10/19/2011EP2376628A2 Production of influenza vaccines
10/19/2011EP1225229B1 Gene transfer method
10/19/2011CN102221618A Method for establishing hog cholera lapinized virus labeled vaccine strain and preparing vaccine
10/19/2011CN102220350A Method for expressing resveratrol stilbene synthase and preparing resveratrol by utilizing insect system
10/19/2011CN102220293A Dog flu recombinant virus as well as preparation method and application thereof
10/19/2011CN102220292A Recombined II-type herpes simplex virus, preparation method and application and tumour diagnostic reagent kit
10/19/2011CN102220291A Duck flavivirus and inactivated vaccine thereof
10/19/2011CN102220290A Cell culture method for duck flavivirus
10/19/2011CN102220289A Cellular permissivity factor for viruses, and uses thereof
10/19/2011CN102220288A Mouse-addapted enterovirus EV71 strain 573 and use thereof
10/19/2011CN102220287A Avian infectious bronchitis cold adaptation attenuated vaccine strain and application thereof
10/19/2011CN102219841A Phytomass-related protein as well as coding gene and application thereof
10/18/2011US8039003 Recombinant attenuated dengue viruses comprising a deletion in the 3′ untranslated region and additional attenuating mutations induced by chemical mutagenesis
10/18/2011US8039002 Influenza hemagglutinin and neuraminidase variants
10/18/2011US8039001 Therapeutic and prophylactic vaccine for the treatment and prevention of papillomavirus infection
10/18/2011CA2561701C Mixed cell diagnostic systems
10/18/2011CA2378326C Dna encoding a plant deoxyhypusine synthase, a plant eukaryotic initiation factor 5a, transgenic plants and a method for controlling senescence and programmed cell death in plants
10/18/2011CA2364934C Method for obtaining a purified viral preparation
10/13/2011WO2011127410A2 System and apparatus for robotic device and methods of using thereof
10/13/2011WO2011127316A1 Method for generating a parvovirus b19 virus-like particle
10/13/2011WO2011125469A1 Micro-rna-regulated recombinant vaccinia virus and utilization thereof
10/13/2011WO2011125054A2 Protein and nucleic acid delivery vehicles, components and mechanisms thereof
10/13/2011WO2011124371A1 Viral particle released after infection of mammalian cells by human cytomegalovirus (hcmv) containing a fusion protein and use thereof
10/13/2011WO2011123945A1 Compostions, methods and uses for treating respiratory syncytial virus infection
10/13/2011WO2011046996A3 Consensus sequence for influenza a virus
10/13/2011US20110251106 Pvii phage display
10/13/2011US20110250693 Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (mva)
10/13/2011US20110250675 Virus-Like Particle Mediated Cellular Delivery
10/13/2011US20110250650 Lentiviral vectors for the preparation of immunotherapeutical compositions
10/13/2011US20110250584 Method for Screening Cancer Therapeutic Agent Using Galectin-3, GSK-3Betta, and Fascin-1
10/13/2011US20110250583 Optimized probes and primers and methods of using same for the binding, detection, differentiation, isolation and sequencing of influenza a; influenza b; novel influenza a/h1n1; and a novel influenza a/h1n1 rna sequence mutation associated with oseltamivir resistance
10/13/2011US20110250263 Protein and nucleic acid delivery vehicles, components and mechanisms thereof
10/13/2011US20110250232 DNA-Transfection System for the Generation of Infectious Influenza Virus
10/13/2011US20110250211 Variable domains of camelid heavy-chain antibodies directed against glial fibrillary acidic proteins
10/13/2011US20110250188 LCMV-GP-VSV-Pseudotyped Vectors and Tumor-Infiltrating Virus-Producing Cells for the Therapy of Tumors
10/13/2011US20110250172 Hepatitis c virus inhibitors
10/13/2011CA2795695A1 Microrna-controlled recombinant vaccinia virus and use thereof
10/13/2011CA2795346A1 Viral particle released after infection of mammalian cells by human cytomegalovirus (hcmv) containing a fusion protein and use thereof
10/12/2011EP2373785A1 Bovine viral diarrhea virus with a modified erns protein
10/12/2011EP2373334A1 High growth reassortant influenza a virus
10/12/2011EP2017333B1 Feline cell capable of being cultured without animal protein, and method for production of virus and method for production of vaccine using the feline cell
10/12/2011CN102216450A Methods for cultivating cells, propagating and purifying viruses
10/12/2011CN102215865A Methods for purification of viruses
10/12/2011CN102212554A Enterovirus type 71 (EV71) infectious clone and construction method
10/12/2011CN102212507A Hypericum sampsonii hance benzophenone synthase and coding genes thereof
10/12/2011CN102212136A ScFv (single chain variable fragment) antibody used for detecting norfloxacin, and encoding gene and application thereof
10/12/2011CN102212133A Fab segment of human-source human immunodeficiency virus (HIV) antibody and coded gene and application thereof
10/12/2011CN102210857A Method for improving antigen amount of inactivated porcine circovirus 2 (PCV2) vaccine
10/12/2011CN101974490B Method for purifying swine fever viruses
10/12/2011CN101659954B Recombinant adenovirus expressing mycoplasma hyopneumoniae P102 protein and applications thereof
10/11/2011US8034617 Cell culture in culture media free of components of animal origin
10/11/2011US8034552 Virulent phages to detect Listeria monocytogenes in foodstuffs and in food processing plants
10/11/2011US8034356 Monoparamunity inducers based on attenuated rabbit myxoma viruses
10/11/2011US8034355 Attenuated nonsegmented negative-sense RNA viruses with reduced mRNA cap methyltransferase activity comprising mutations within conserved domain VI of the large polymerase
10/11/2011US8034354 Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (MVA)
10/11/2011CA2476405C Compositions and methods for treatment of microbial infections
10/11/2011CA2341356C Poxvirus with targeted infection specificity
10/11/2011CA2157932C Production of human papillomavirus capsid protein and virus-like particles
10/06/2011WO2011122950A1 Monomeric duplex aav vectors
10/06/2011WO2011121306A1 Stabilisation of viral particles
10/06/2011US20110245186 Recombinant e-selectin made in insect cells
10/06/2011US20110244576 Herpes Simplex Virus Complex
10/06/2011US20110244574 Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (mva)
1 ... 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 ... 267